Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Minami

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Ejhaem|April 15, 2026
Reciprocal Clonal Dynamics of Independent <i>FLT3</i> D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With GilteritinibKai Osone, Seiichiro Katagiri, SungGi Chi, et al.
Blood|July 5, 2003
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemiaYosuke Minami, Kazuhito Yamamoto, Hitoshi Kiyoi, et al.
International Journal of Hematology|March 31, 2026
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 studyFumiya Ogasawara, Yosuke Minami, SungGi Chi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 7, 2020
[Vascular adverse events of ponatinib during treatment of Philadelphia chromosome-positive leukemia: a retrospective single-institution analysis]Nobue Sato, Junichiro Yuda, Nobuhiko Yamauchi, et al.
International Journal of Hematology|October 22, 2010
Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatmentYosuke Minami, Tomohiro Kajiguchi, Akihiro Abe, et al.
Journal of Medical Case Reports|March 25, 2021
Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reportsJunichiro Yuda, Nobuhiko Yamauchi, Ayumi Kuzume, et al.
African Journal of Paediatric Surgery : AJPS|March 1, 2024
Pre-operative Serum Albumin Predicts Native Liver Survival in Biliary AtresiaKakeru Machino, Kotaro Mimori, Seiya Ogata, et al.
Cancer Science|December 15, 2018
Potent antiproliferative effect of fatty-acid derivative AIC-47 on leukemic mice harboring BCR-ABL mutationHaruka Shinohara, Nobuhiko Sugito, Yuki Kuranaga, et al.
International Journal of Molecular Sciences|January 11, 2024
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy SyndromeHironori Arai, Hirotaka Matsui, SungGi Chi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiationTakahiko Yasuda, Fumihiko Hayakawa, Shingo Kurahashi, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Ejhaem|April 15, 2026
Reciprocal Clonal Dynamics of Independent <i>FLT3</i> D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With GilteritinibKai Osone, Seiichiro Katagiri, SungGi Chi, et al.
Blood|July 5, 2003
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemiaYosuke Minami, Kazuhito Yamamoto, Hitoshi Kiyoi, et al.
International Journal of Hematology|March 31, 2026
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 studyFumiya Ogasawara, Yosuke Minami, SungGi Chi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 7, 2020
[Vascular adverse events of ponatinib during treatment of Philadelphia chromosome-positive leukemia: a retrospective single-institution analysis]Nobue Sato, Junichiro Yuda, Nobuhiko Yamauchi, et al.
International Journal of Hematology|October 22, 2010
Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatmentYosuke Minami, Tomohiro Kajiguchi, Akihiro Abe, et al.
Journal of Medical Case Reports|March 25, 2021
Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reportsJunichiro Yuda, Nobuhiko Yamauchi, Ayumi Kuzume, et al.
African Journal of Paediatric Surgery : AJPS|March 1, 2024
Pre-operative Serum Albumin Predicts Native Liver Survival in Biliary AtresiaKakeru Machino, Kotaro Mimori, Seiya Ogata, et al.
Cancer Science|December 15, 2018
Potent antiproliferative effect of fatty-acid derivative AIC-47 on leukemic mice harboring BCR-ABL mutationHaruka Shinohara, Nobuhiko Sugito, Yuki Kuranaga, et al.
International Journal of Molecular Sciences|January 11, 2024
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy SyndromeHironori Arai, Hirotaka Matsui, SungGi Chi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiationTakahiko Yasuda, Fumihiko Hayakawa, Shingo Kurahashi, et al.
Pageof 11